Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
It was developed in the 1990s by researchers at Monash University in Melbourne, Australia, with one goal: isolate the fat-burning portion of growth hormone and deliver those effects without the risks that come with full hGH administration
AOD-9604 works gradually, producing visible changes over weeks and months rather than days
Research has examined its role in: 3-adrenergic receptor upregulation and adipose tissue sensitisation studies Lipolysis stimulation and plasma glycerol elevation in adipocyte models Lipogenesis inhibition and fat accumulation prevention in diet-induced obesity models Fat oxidation and energy expenditure pathway research Metabolic flexibility and substrate oxidation studies in obese murine models Cartilage regeneration and intra-articular joint biology in osteoarthritis models Safety pharmacology genotoxicity, bioavailability, and plasma kinetics profiling Comparative hGH fragment activity studies alongside AOD9401 and native hGH AOD9604 and Adipose Tissue Research In obese Zucker rats treated with oral AOD9604 at 500 g/kg body weight for 19 days, over 50% reduction in body weight gain was observed compared to controls, accompanied by significantly increased lipolytic activity in adipose tissue
In the single source study, AHK-Cu stimulated the proliferation of cultured human DPCs and the elongation of isolated human hair follicles at very low concentrations (1010 M), raised the Bcl-2/Bax ratio and lowered cleaved caspase-3 and PARP though the drop in apoptotic-cell count itself was not statistically significant [1]
Helped give me the energy to push through my insanely busy lifestyle
Unless you're microdosing, 2 mL per vial is a solid rule of thumb
US$ 22.21
US$ 23.98
US$ 20.19
US$ 21.83
US$ 20.85
